2019
DOI: 10.5114/wiitm.2019.86800
|View full text |Cite
|
Sign up to set email alerts
|

Gender-related metabolic outcomes of laparoscopic sleeve gastrectomy in 6-month follow-up.

Abstract: Introduction: Laparoscopic sleeve gastrectomy (LSG) is recently a leading method in surgical treatment of morbid obesity. The metabolic outcome of intervention may be a result of many factors such as age, gender, preoperative weight loss and dietary restrictions. Aim: To evaluate gender-related differences in the results of LSG in 6-month follow-up. Material and methods: The study included 101 patients who underwent LSG at the University Clinical Hospital of Bialystok. Patients were divided and analyzed in 2 g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…A study conducted by Kirkpatrick et al revealed a reduction in liver enzymes including ALT (66.21 vs. 28.58) and AST (46.28 vs. 24.69) during 12 months of observation [ 32 ]. Groth et al also observed an amelioration in the liver enzymes profile in patients undergoing laparoscopic sleeve gastrectomy during 6 months of follow up (AST 22.0 (19.0–28.0) vs. 16.0 (13.0–22.0), p < 0.001, and ALT 27.5 (20.5–41.0) vs. 19.0 (15.0–27.0), p < 0.001) with no statistical differences regarding gender ( p = 0.840) [ 33 ]. Similar results were observed in our study.…”
Section: Discussionmentioning
confidence: 99%
“…A study conducted by Kirkpatrick et al revealed a reduction in liver enzymes including ALT (66.21 vs. 28.58) and AST (46.28 vs. 24.69) during 12 months of observation [ 32 ]. Groth et al also observed an amelioration in the liver enzymes profile in patients undergoing laparoscopic sleeve gastrectomy during 6 months of follow up (AST 22.0 (19.0–28.0) vs. 16.0 (13.0–22.0), p < 0.001, and ALT 27.5 (20.5–41.0) vs. 19.0 (15.0–27.0), p < 0.001) with no statistical differences regarding gender ( p = 0.840) [ 33 ]. Similar results were observed in our study.…”
Section: Discussionmentioning
confidence: 99%
“…However, females are significantly more successful on pharmacotherapy for weight loss ( 9 ). Moreover, there is no consensus in clinic in terms of the sex-related differences in the weight-loss effect after SG ( 10 , 11 ). As mentioned above, further research is needed to illustrate the sex differences in the weight-loss effect after SG.…”
Section: Introductionmentioning
confidence: 99%